Bigmoney Dreamer
commented on
$Humacyte (HUMA.US)$ Look at the price target from two days ago..$25..
Do you think that is a credibility issue maybe they raise this company some money along the way and they need to be bullish to get potential business from them in the future.
Do you think that is a credibility issue maybe they raise this company some money along the way and they need to be bullish to get potential business from them in the future.
1
5
Bigmoney Dreamer
commented on
$Verrica Pharmaceuticals (VRCA.US)$ why this guy dropped much? i am trying to make sense of it but can find a good reason...anyone inside?
2
Bigmoney Dreamer
commented on
$NextNav (NN.US)$
The risk associated with trading NextNav Inc. is moderately high due to its negative EBITDA and overall unprofitability, increasing uncertainty about its long-term sustainability. The stock's high volatility implies the potential for swift price changes, leading to the possibility of significant losses. Additionally, the lack of significant recent news may present gaps in traders' insight into future performance. However, the proximity to key resistance and support levels could ...
The risk associated with trading NextNav Inc. is moderately high due to its negative EBITDA and overall unprofitability, increasing uncertainty about its long-term sustainability. The stock's high volatility implies the potential for swift price changes, leading to the possibility of significant losses. Additionally, the lack of significant recent news may present gaps in traders' insight into future performance. However, the proximity to key resistance and support levels could ...
6
18
Bigmoney Dreamer
liked and commented on
$NextNav (NN.US)$ 👀12.75$ mental target without buying ( no buying due to high risk level 8/10 scale) hit !
Bigmoney Dreamer
commented on
$Trump Media & Technology (DJT.US)$
Investing in DJT presents a significant level of risk, rating at a 9/10. This is due to the heavy financial losses and negative operational cash flow, which reflect deeper liquidity and profitability issues. The volatility indicated by recent trading activity and significant price oscillations further heightens risk for traders. The absence of positive news or catalysts, coupled with its sector underperformance, signals a challenging outlook. Additionally, the...
Investing in DJT presents a significant level of risk, rating at a 9/10. This is due to the heavy financial losses and negative operational cash flow, which reflect deeper liquidity and profitability issues. The volatility indicated by recent trading activity and significant price oscillations further heightens risk for traders. The absence of positive news or catalysts, coupled with its sector underperformance, signals a challenging outlook. Additionally, the...
5
5
$Verona Pharma (VRNA.US)$
Given the current performance and sector conditions, Verona Pharma poses a moderately high risk 7.5/10, for a trader's portfolio. The company is not profitable, which elevates its risk profile despite the ample cash reserves that provide a financial cushion. The significant positive news may drive short-term gains, but reliance on future drug approvals carries inherent speculative risk. The biotech sector's low interest may dampen broader market enthusiasm, although stoc...
Given the current performance and sector conditions, Verona Pharma poses a moderately high risk 7.5/10, for a trader's portfolio. The company is not profitable, which elevates its risk profile despite the ample cash reserves that provide a financial cushion. The significant positive news may drive short-term gains, but reliance on future drug approvals carries inherent speculative risk. The biotech sector's low interest may dampen broader market enthusiasm, although stoc...
3
Bigmoney Dreamer
commented on
$LexinFintech (LX.US)$
The risk level of LexinFintech's stock is assessed at a moderate level due to its relatively stable financials and liquidity, yet lacking visibility in a hot-sector. While the company is financially sound, the stock does not currently trade near its 52-week high, presenting some uncertainty compared to peers thriving in booming industries. Market sentiment remains mostly positive, but LX's susceptibility to sectorial shifts in fintech necessitates cautious monitoring. Its p...
The risk level of LexinFintech's stock is assessed at a moderate level due to its relatively stable financials and liquidity, yet lacking visibility in a hot-sector. While the company is financially sound, the stock does not currently trade near its 52-week high, presenting some uncertainty compared to peers thriving in booming industries. Market sentiment remains mostly positive, but LX's susceptibility to sectorial shifts in fintech necessitates cautious monitoring. Its p...
6
2